Teva Parenteral Medicines, Inc.
NDC labeler code: 0703
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- CarboplatinKyxata · 8 products
- PaclitaxelPaclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound), Paclitaxel Protein Bound Particles Albumin Bound, Abraxane · 7 products
- Sulfamethoxazole and trimethoprimSulfatrim, Sulfamethoxazole and Trimethoprim Ds, Bactrim Ds · 6 products
- TreprostinilTyvaso Dpi, Orenitram, Remodulin · 4 products
- Hydromorphone hydrochlorideDilaudid · 3 products
- MethotrexateRasuvo, Otrexup, Trexall · 3 products
- Triamcinolone acetonideKenalog-40, Triderm, Kenalog-10 · 2 products
- MetoclopramideReglan, Gimoti · 2 products
- CisplatinAxycis · 2 products
- Palonosetron hydrochloridePosfrea · 1 product
FDA applications for these products
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| September 26, 2019 | ANDA206648 | Treprostinil TREPROSTINIL | Teva Pharms USA |
| October 5, 2018 | ANDA209852 | Triamcinolone acetonide TRIAMCINOLONE ACETONIDE | Teva Pharms USA |
| March 23, 2018 | ANDA090713 | Palonosetron hydrochloride PALONOSETRON HYDROCHLORIDE | Teva Pharms USA |
| January 8, 2010 | ANDA040843 | Methotrexate METHOTREXATE SODIUM PRESERVATIVE FREE | Pharmachemie Bv |
| June 17, 2008 | ANDA078591 | Hydromorphone hydrochloride HYDROMORPHONE HYDROCHLORIDE | Hospira Inc |
| October 14, 2004 | ANDA077269 | Carboplatin CARBOPLATIN | Pharmachemie Bv |
| January 25, 2002 | ANDA075184 | Paclitaxel PACLITAXEL | Teva Pharms |
| May 16, 2000 | ANDA074656 | Cisplatin CISPLATIN | Pharmachemie Bv |
| November 27, 1991 | ANDA073135 | Metoclopramide METOCLOPRAMIDE HYDROCHLORIDE | Teva Pharms USA |
| October 31, 1991 | ANDA073303 | Sulfamethoxazole and trimethoprim SULFAMETHOXAZOLE AND TRIMETHOPRIM | Teva Pharms USA |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2021
-
July 29, 2021 · Class II · Terminated · D-0741-2021 · Metoclopramide
Lack of Assurance of Sterility
Metoclopramide Injection USP, 10 mg/2mL (5 mg/mL) 2 mL single-use vial, Rx only, Teva Parenteral Medicines, Inc. Irvine, CA 92618, NDC 0703-4502-01
-
April 26, 2021 · Class II · Terminated · D-0377-2021 · Metoclopramide
Lack of Assurance of Sterility
Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial, Rx Only, TEVA Parenteral Medicines, Inc. Irvine, CA 92618 NDC 0703-4502-04
-
February 15, 2021 · Class II · Terminated · D-0297-2021 · Metoclopramide
Chemical contamination; Unknown brown residue adhering to the inside of one vial.
Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceuticals, USA, Inc., Parsippany, NJ Vial NDC 0703-4502-01 (vial) NDC# 0703-4502-04 (tray)
-
February 10, 2021 · Class II · Terminated · D-0277-2021 · Metoclopramide
Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.
Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial NDC 0703-4502-01), packaged in 25 x 2 mL Single-Use Vials per tray (NDC 0703-4502-04), Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618.
2018
-
February 7, 2018 · Class I · Terminated · D-0596-2018 · Hydromorphone hydrochloride
Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.
Hydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High Potency Formulation. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618. NDC: 0703-0110-01
2017
-
July 26, 2017 · Class II · Terminated · D-1080-2017 · Hydromorphone hydrochloride
Presence of Particulate Matter: Silicone oil
Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA. NDC: 0703-0018-01
-
July 26, 2017 · Class II · Terminated · D-1082-2017 · Hydromorphone hydrochloride
Presence of Particulate Matter: Silicone oil
Hydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL), 5 mL Single Dose Vial.(10 vials per carton NDC 0703-0113-01) and 180 vials per case (NDC 0703-0113-03) Mfd By: Hospira, Inc., Lake Forest, IL 60045 USA,
2014
-
October 1, 2014 · Class II · Terminated · D-0044-2015 · Hydromorphone hydrochloride
Lack Of Assurance Of Sterility: Confirmed customer complaints of glass product container vials that may be broken or cracked.
Hydromorphone Hydrochloride Injection, USP, 10 mg/mL, Rx only, packaged in a) 1 mL Single-dose Vial (NDC 0703-0110-01), packaged in 10 x 1 mL Single-dose Vials per carton (NDC 0703-0110-03); Mfd By: Hospira Inc., Lake Fo
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026